RxDoctor Payments Data

Roland Jones, MD

Pain Medicine · Tallahassee, FLNPI 1720074610

Payments from drug & device makers

$14,969in general payments, 2019–2025

Across 851 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Abbott$2K
  • Amgen$933
  • Boston Scientific$819
  • Collegium Pharmaceutical, Inc.$749
  • Nevro Corp.$691
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,969100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)184$2,547
Abbott99$1,973
Amgen(2 entities)54$933
Boston Scientific25$819
Collegium Pharmaceutical, Inc.56$749
Nevro Corp.38$691
Pfizer34$649
UCB, Inc.26$568
Lundbeck LLC21$482
Teva Pharmaceuticals USA, Inc.24$436
Novartis21$391
Medtronic(2 entities)14$363
Supernus Pharmaceuticals, Inc.27$291
Lilly USA, LLC17$284
CSL Behring14$277
SK Life Science, Inc.13$254
Sanofi14$242
Scilex Pharmaceuticals Inc.16$241
Grifols USA, LLC11$214
Neurelis, Inc.11$209
Eisai Inc.8$179
AstraZeneca8$168
Neurocrine Biosciences, Inc.9$168
Biogen9$161
Arbor Pharmaceuticals, Inc.9$131
Almatica Pharma LLC7$129
Biohaven Pharmaceuticals, Inc.7$108
Biohaven Pharmaceutical Holding Company Ltd.6$107
Bristol Myers Squibb5$98
Acadia Pharmaceuticals Inc5$92
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$87
Idorsia Pharmaceuticals US Inc5$84
Otsuka America Pharmaceutical, Inc.3$57
Amneal Pharmaceuticals LLC3$56
Assertio Therapeutics, Inc.4$55
Globus Medical3$53
Impel Pharmaceuticals Inc.2$43
Indivior Inc.2$43
Johnson & Johnson2$43
Takeda Pharmaceuticals U.S.A., Inc.3$37
Redhill Biopharma Inc.2$32
SPR Therapeutics, Inc1$31
Daiichi Sankyo Inc.2$31
Axsome Therapeutics, Inc.1$27
Tonix Medicines, Inc.1$26
Argenx US, Inc.1$26
Pacira Therapeutics, Inc.1$25
Sunovion Pharmaceuticals Inc.1$24
Averitas Pharma Inc.1$18
Genentech USA, Inc.1$18
Vertex1$17
Pacira Pharmaceuticals Incorporated1$17
Acorda Therapeutics, Inc1$16
TG Therapeutics, Inc.1$16
Biodelivery Sciences International, Inc.1$15
Kowa Pharmaceuticals America, Inc.1$15
Nalu Medical, Inc.1$13
Zyla Life Sciences, Inc.1$13
Tanabe Pharma America, Inc.1$13
Mallinckrodt Hospital Products Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,969 in reported general payments places this provider in the 85th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$838,624
Medicare patients
553
Services billed
19,540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate196$118,022
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,328$99,473
BotoxOnabotulinumtoxina53$73,965
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,326$73,884
PercocetOxycodone Hcl/Acetaminophen13$58,878
Nucynta ErTapentadol Hcl41$41,668
UbrelvyUbrogepant26$40,358
NucyntaTapentadol Hcl25$33,223
BelbucaBuprenorphine Hcl30$24,725
Fentanyl87$16,122
Morphine Sulfate ErMorphine Sulfate626$15,350
QuliptaAtogepant14$15,340
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl80$14,215
Buprenorphine59$13,658
Oxycodone Hcl779$11,926

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta, Belbuca$749$217,638292 claims
AbbVieBotox, Ubrelvy, Qulipta$2,547$129,66393 claims
Amneal Pharmaceuticals LLCRytary$56$9,51412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 596 pain medicine providers in Florida.

Other pain medicine in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →